AffiAB® Anti-Hu CD264 FITC [TRAIL-R4-01]

https://www.affiab.com/web/image/product.template/109910/image_1920?unique=d31c23b
(0 review)

CAT# AFG-EXB-1242
Size: 100 Tests

333.50 333.5 USD 333.50

333.50

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

TRAIL-R4 (CD264, TR4, DcR2, TRUNDD), expressed mainly on CD8+ and NK cells, belongs to receptors of TRAIL, a TNF-like membrane toxic protein that induces apoptosis in many tumour cells, but not in normal cells. TRAIL-R4, however, contains partially truncated death domain, thus it is unable to induce apoptosis and serves as a negative regulator of apoptotic signaling by impairment death-inducing signaling complex (DISC) processing. TRAIL-R4 interacts with death receptor 5 (DR5) in the native DISC in a TRAIL-dependent manner and prevents its corecruitment with death receptor 4 (DR4) .


Specificity:

The antibody TRAIL-R4-01 reacts with an extracellular epitope of TRAIL-R4, a 42 kDa transmembrane protein expressed on various blood cells.

Antigen

CD264

Clone

TRAIL-R4-01

Species Reactivity

Human

Negative Species

N/A

Isotype

Mouse IgG1

Immunogen

TRAIL-R4 (aa 1-210) - hIgGhc fusion protein

Application

FC (QC tested)

Regulatory status

RUO

Concentration

0.1 mg/ml

Format

FITC

Storage / Stability

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Storage Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide